Evidence map›Paper›PMID 41497617›Full record

ArticlebioRxiv : the preprint server for biology2025

High-resolution binding data of TFIID and cofactors show promoter-specific differences

Sergio G-M Alcantara, Simon Bourdareau, Melanie Weilert, Julia Zeitlinger

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sergio G-M AlcantaraStowers Institute for Medical Research, Kansas City, MO, USA.ORCID 0000-0003-3695-4677
Simon BourdareauStowers Institute for Medical Research, Kansas City, MO, USA.ORCID 0000-0001-9150-5327
Melanie WeilertStowers Institute for Medical Research, Kansas City, MO, USA.ORCID 0000-0001-8683-4580
Julia ZeitlingerStowers Institute for Medical Research, Kansas City, MO, USA.ORCID 0000-0002-5172-3335

Funding

A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolutionR01HG010211 · NHGRI · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI ZEITLINGER, JULIA · 2018 to 2021
$2.3M
NHGRI NIH HHS R01 HG010211
6 · The paper itself

Abstract

TFIID is instrumental in recognizing promoter sequences and initiating transcription, yet a cohesive understanding of how this complex interacts with and functions at different promoter types

Indexed as

ChIP-nexusDrosophila kc167cellsNC2promoter selectionTBPTFIIDtranscriptional bursting

Identifiers

PMID41497617
PMCPMC12767524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.